 | Monter d'un niveau |
David, S., Tran, T., Dallaire, F., Sheehy, G., Azzi, F., Trudel, D., Tremblay, F., Omeroglu, A., Leblond, F., & Meterissian, S. (2023). In situ Raman spectroscopy and machine learning unveil biomolecular alterations in invasive breast cancer. Journal of Biomedical Optics, 28(3), 036009 (18 pages). Lien externe
David, S., Plante, A., Dallaire, F., Tremblay, J.-P., Sheehy, G., Macdonald, E., Forrest, L., Daneshmand, M., Trudel, D., Wilson, B. C., Hopkins, L., Murugkar, S., Vanderhyden, B., & Leblond, F. (2022). Multispectral label-free Raman spectroscopy can detect ovarian and endometrial cancer with high accuracy. Journal of Biophotonics, 15(2), 10 pages. Lien externe
Grajales, D., Le, W., Dallaire, F., Sheehy, G., David, S., Tran, T., Leblond, F., Menard, C., & Kadoury, S. (octobre 2023). Towards Real-Time Confirmation of Breast Cancer in the OR Using CNN-Based Raman Spectroscopy Classification [Communication écrite]. 2nd International Workshop on Cancer Prevention Through Early Detection (CaPTion 2023), Vancouver, BC, Canada. Lien externe
